IL95057A - Recombinant gene coding for a protein possessing urate oxidase activity - Google Patents

Recombinant gene coding for a protein possessing urate oxidase activity

Info

Publication number
IL95057A
IL95057A IL95057A IL9505790A IL95057A IL 95057 A IL95057 A IL 95057A IL 95057 A IL95057 A IL 95057A IL 9505790 A IL9505790 A IL 9505790A IL 95057 A IL95057 A IL 95057A
Authority
IL
Israel
Prior art keywords
oxidase activity
gene coding
urate oxidase
recombinant gene
protein possessing
Prior art date
Application number
IL95057A
Other languages
English (en)
Other versions
IL95057A0 (en
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Richard Legoux
Gerard Loison
Elisabeth Larbre
Johannes Lupker
Pascal Leplatois
Marc Salome
Patrick Laurent
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8909550A external-priority patent/FR2649720A1/fr
Priority claimed from FR8917466A external-priority patent/FR2656530B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL95057A0 publication Critical patent/IL95057A0/xx
Publication of IL95057A publication Critical patent/IL95057A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
IL95057A 1989-07-13 1990-07-12 Recombinant gene coding for a protein possessing urate oxidase activity IL95057A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8909550A FR2649720A1 (en) 1989-07-13 1989-07-13 Recombinant gene which encodes a protein such as urate oxidase
FR8917466A FR2656530B1 (fr) 1989-12-29 1989-12-29 Gene recombinant pour une expression dans les cellules eucaryotes d'une proteine telle que l'urate oxydase.
FR9001368A FR2657785A2 (fr) 1989-12-29 1990-02-06 Gene recombinant pour une expression dans les cellules animales d'une proteine telle que l'urate oxydage.

Publications (2)

Publication Number Publication Date
IL95057A0 IL95057A0 (en) 1991-06-10
IL95057A true IL95057A (en) 1997-07-13

Family

ID=27251947

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95057A IL95057A (en) 1989-07-13 1990-07-12 Recombinant gene coding for a protein possessing urate oxidase activity

Country Status (23)

Country Link
EP (1) EP0408461B1 (ja)
JP (1) JP2664804B2 (ja)
AT (1) ATE144282T1 (ja)
AU (1) AU636637B2 (ja)
BR (1) BR9006855A (ja)
CA (1) CA2035900C (ja)
DE (2) DE10199042I2 (ja)
DK (1) DK0408461T3 (ja)
ES (1) ES2095243T3 (ja)
FI (1) FI105047B (ja)
GR (1) GR3022085T3 (ja)
HU (1) HU215948B (ja)
IE (1) IE77158B1 (ja)
IL (1) IL95057A (ja)
LU (1) LU90781I2 (ja)
LV (1) LV12000B (ja)
MC (1) MC2145A1 (ja)
NL (1) NL300046I2 (ja)
NO (1) NO2001018I2 (ja)
NZ (1) NZ234453A (ja)
PT (1) PT94680B (ja)
RU (1) RU2105812C1 (ja)
WO (1) WO1991000909A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2971218B2 (ja) * 1991-12-04 1999-11-02 協和醗酵工業株式会社 ウリカーゼ遺伝子およびウリカーゼの製造法
US5691188A (en) 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
PT1538202E (pt) * 1996-09-13 2014-04-22 Shire Human Genetic Therapies Produção de alga-galactosidase a humana
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
EP1100542B1 (en) * 1998-08-06 2005-06-22 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
BR0113304A (pt) 2000-08-17 2004-01-06 Ajinomoto Kk Método para planejar e preparar uma transglutaminase mutante, mtg mutante transglutaminase mutante, gene, dna recombinante, microorganismos, método para produzir uma mtg mutante ou uma transglutaminase mutante, e, cristais de mtg monoclìnicos
BR122017016940B8 (pt) 2002-04-25 2021-07-27 Transkaryotic Therapies Inc método para preparação de uma composição farmacêutica compreendendo alfa-galactosidase a
WO2008051178A2 (en) * 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
DK3321359T3 (da) 2005-04-11 2021-03-08 Horizon Pharma Rheumatology Llc Variante former af uratoxidase og anvendelse deraf
CN102807973A (zh) 2005-04-11 2012-12-05 萨文特医药公司 尿酸氧化酶的变体形式及其用途
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
RU2443426C2 (ru) * 2008-11-07 2012-02-27 Мунтэн Вью Фармасьютикэлз, Инк. Конъюгаты уратоксидазы, фармацевтическая композиция для снижения уровней мочевой кислоты и способ получения вышеупомянутых конъюгатов
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
EP3538135A4 (en) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC POLYTHERAPIES OF PREDNISONE AND URICASE MOLECULES AND THEIR USES
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
CN109223707B (zh) * 2018-09-13 2020-12-08 中国药科大学 一种尿酸酶外用凝胶制剂、其制备方法及用途
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers
CN120624388B (zh) * 2025-06-16 2026-04-24 大理大学 一种耐热性尿酸氧化酶tc1-uox2及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6301M (ja) * 1967-03-29 1968-09-09
SU457723A1 (ru) * 1973-04-09 1977-08-05 Всесоюзный Научно-Исследовательский Витаминный Институт Штамм 313-152 - продуцент уратоксидазы
CA1341130C (en) * 1984-07-27 2000-10-31 Adrianus Marinus Ledeboer Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
WO1988008450A1 (en) * 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
JPH0671428B2 (ja) * 1988-08-17 1994-09-14 サッポロビール株式会社 ウリカーゼのｄｎａ配列および製法

Also Published As

Publication number Publication date
EP0408461B1 (fr) 1996-10-16
CA2035900C (fr) 2000-01-11
IE77158B1 (en) 1997-12-03
LV12000B (lv) 1998-06-20
EP0408461A1 (fr) 1991-01-16
PT94680B (pt) 1997-04-30
NL300046I1 (nl) 2001-09-03
HUT56884A (en) 1991-10-28
ATE144282T1 (de) 1996-11-15
LV12000A (lv) 1998-03-20
FI105047B (fi) 2000-05-31
FI911212A0 (fi) 1991-03-12
IE902559A1 (en) 1991-02-27
NO2001018I2 (no) 2006-05-01
IL95057A0 (en) 1991-06-10
HU215948B (hu) 1999-03-29
NL300046I2 (nl) 2001-12-01
ES2095243T3 (es) 1997-02-16
LU90781I2 (fr) 2001-07-23
DK0408461T3 (da) 1997-03-24
JPH04501807A (ja) 1992-04-02
PT94680A (pt) 1991-04-18
CA2035900A1 (fr) 1991-01-14
HU906046D0 (en) 1991-07-29
MC2145A1 (fr) 1992-02-18
JP2664804B2 (ja) 1997-10-22
HK1000099A1 (en) 1997-11-21
RU2105812C1 (ru) 1998-02-27
WO1991000909A1 (fr) 1991-01-24
DE10199042I2 (de) 2003-10-23
NZ234453A (en) 1993-01-27
DE69028884D1 (de) 1996-11-21
AU6052390A (en) 1991-02-06
GR3022085T3 (en) 1997-03-31
BR9006855A (pt) 1991-08-06
DE10199042I1 (de) 2002-01-10
AU636637B2 (en) 1993-05-06
DE69028884T2 (de) 1997-05-07

Similar Documents

Publication Publication Date Title
AU3545684A (en) Independent suspension using c.v.j:s
ES8704976A1 (es) Metodo pra la fabricacion de un polipeptido firiologicamente activo en el hombre.
IE870074L (en) 4,5,6 - substituted -2- pyrimidinamines
KR0180256B1 (en) Bpc peptides, their preparation and use
AU4614689A (en) A gene and gene structure coding for an aminotransferase, and microorganisms which express this gene
DE69230535D1 (en) Polyphenol oxidase gene
EP0292220A3 (en) Condom
AU1024488A (en) Scorch-resistant, curable fluorinated elastomer
AU1384688A (en) 1,5-substituted 1H-imidazoles
CA2014948A1 (en) Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity
AU3979989A (en) Dna encoding human monoamine oxidase type a
AU570572B2 (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
AU2280192A (en) Recombinant dna coding for a protein with endochitinase activity
AU6910991A (en) The scl gene, and the encoded hematopoietic factor
CA2066263A1 (en) Tsh receptor
AU591892B2 (en) Peptides
EP0549062A3 (ja)
AU5627090A (en) A novel alpha-amylase-pullulanase enzyme, a dna sequence coding the same, a recombinant dna molecule and a recombinant clone expressing the enzyme
IL89391A0 (en) Structural gene coding for an insecticidal endotoxin protein,said protein,its production and use of said gene and protein
AU6403590A (en) Isolated, physiologically active human thrombomodulin polypeptide
CA2067176A1 (en) Recombinant gene coding for a protein having an endochitinase activity
BG102479A (en) Mew peptides, method for their preparation and application
AU643701B2 (en) 1-ethylphenoxathiin 10,10-dioxide
EP0222726A3 (en) Mutant coding sequence
AU5239290A (en) Purification of c.pseudotuberculosis toxin, and cloning and expression of toxin gene

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed